About the Event:
WCG is an exhibitor and poster presenter at this year’s CAR-TCR Summit. As the industry reaches an inflection point and CAR-TCR therapies enter the commercial setting at increasing velocity, now is the time to join with all the key stakeholders to share strategies from early phase development to market access and commercial readiness. Gain end-to-end insights from established thought leaders, and the innovators bringing disruptive technologies from bench to bedside, and from vein tovein.
The Cell & Gene Therapy team at WCG has curated solutions designed to ensure efficiency, compliance, and safety. If you’d like to see how our team can provide insights to support your C> trial, fill out the form to request a complimentary consultation.
Explore Our Services for Cell & Gene Therapy:
Experience an 80% reduction in clinical endpoint errors.
IBC Review and Administration
WCG IBC Services has reviewed more human gene transfer protocols than any other organization.
Site Identification and Feasibility
We have performance data on 160k PI’s globally. We can tell you which sites are most likely to enroll participants for your trial.
Our solution allows automated crediting for completed training, eliminating redundanc and saving sites more than 200 hours on each study.
Our patient recruitment and retention services have demonstrated a 44% increase in patient enrollment.
Our expertise saves, on average 32 days in the completion of the adjudication process.